TYBR Health has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, TYBR Health is raising up to $2,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About TYBR Health
Medical technology and regenerative medicine company dedicated to advancing patient recovery solutions. Our vision is to revolutionize the post-surgery experience and empower patients on their healing journey. With a team of passionate innovators, were committed to developing cutting-edge biomaterial therapies that simplify recovery, reduce complications, and enhance patient outcomes. Orthopedic surgeons value speed and efficiency. That’s why TYBR is developing an extracellular matrix (ECM) barrier that is quick, reliable, cost-effective, and will make a meaningful difference in post-op recovery. This ECM barrier promises to protect complex, soft tissue structures while also increasing functionality and facilitating a timely, full recovery.
To learn more about TYBR Health, visit http://tybrhealth.com/
TYBR Health Linkedin Page: https://www.linkedin.com/company/tybr-health/
Contact:
Timothy Keane, Chief Executive Officer
832-384-5423
https://www.linkedin.com/in/timjkeanejr/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.